Mabpharm Limited — Capital/Financing Update 2019

May 20, 2019

Please use this form if you want the Hong Kong Offer Shares to be issued in your name 如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

This Application Form uses the same terms as defined in the prospectus of Mabpharm Limited (the “Company”) dated May 20, 2019 (the “Prospectus”). 本申請表格使用邁博藥業有限公司（「本公司」）於 2019 年 5 月 20 日刊發的招股章程（「招股章程」）所界定的詞語。 Neither this Application Form nor the Prospectus constitutes an offer to sell or the solicitation of an offer to buy any Hong Kong Offer Shares in any Staple your jurisdiction other than Hong Kong. The Hong Kong Offer Shares may not be offered or sold in the United States without registration or an exemption from registration under the U.S. Securities Act. payment here 本申請表格及招股章程概不構成在香港以外任何司法權區要約出售或游說要約購買任何香港發售股份。若無根據美國證券法登記或豁 免登記，香港發售股份不得在美國提呈發售或出售。 請將股款 This Application Form and the Prospectus may not be forwarded or distributed or reproduced (in whole or in part) in any manner whatsoever in any 緊釘在此 jurisdiction where such forwarding, distribution or reproduction is not permitted under the law of that jurisdiction.在任何根據當地法例不得發送、派發或轉載本申請表格及招股章程的司法權區內概不得以任何方式發送或派發或轉載（不論全部或部 分）本申請表格及招股章程。 Copies of the Prospectus, all related Application Forms and the other documents specified in the paragraph headed “1. Documents delivered to the Registrar of Companies” in Appendix V to the Prospectus, have been registered by the Registrar of Companies in Hong Kong as required by section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong). Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the “Stock Exchange”), Hong Kong Securities Clearing Company Limited (“HKSCC”), the Securities and Futures Commission of Hong Kong (the “SFC”) and the Registrar of Companies in Hong Kong take no responsibility for the contents of these documents. 招股章程、所有相關申請表格及招股章程附錄五「1. 送呈公司註冊處處長文件」一段所述其他文件已按香港法例第 32 章公司（清盤及雜 項條文）條例第 342C 條規定送呈香港公司註冊處處長登記。香港交易及結算所有限公司、香港聯合交易所有限公司（「聯交所」）、香港 中央結算有限公司（「香港結算」）、香港證券及期貨事務監察委員會（「證監會」）及香港公司註冊處處長對此等文件的內容概不負責。 Mabpharm Limited 邁博藥業有限公司 (Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立的有限公司） Stock code : 2181 股份代號 : 2181 Maximum Offer Price : HK$1.95 per Offer Share, plus brokerage fee of 1.0%, SFC transaction levy of 0.0027% and Stock Exchange trading fee of 0.005% (payable in full on application in Hong Kong dollars and subject to refund) (If the Offer Price is set at 10% below the bottom end of the indicative Offer Price after making a Downward Offer Price Adjustment, the Offer Price will be HK$1.35 per Hong Kong Offer Share) 最高發售價 : 每股發售股份 1.95 港元，另加 1.0% 經紀佣金、0.0027% 證監會交易徵費及 0.005% 聯交所交易費（須於申請時以港 元繳足，多繳股款可予退還）（如按發售價下調機制將發售 價下調至指示性發售價範圍下限的 10% 以下，發售價將為 每股發售股份 1.35 港元） You should read this Application Form in conjunction with the Prospectus, which contains further information on the application procedures. ， 一 。 招股章程尚有關於申請程序的其他資料 本申請表格應與招股章程 併閱讀 Application Form 申請表格 To: Mabpharm Limited 致： 邁博藥業有限公司 Sole Global Coordinator 獨家全球協調人 Sole Sponsor 獨家保薦人 Sole Bookrunner 獨家賬簿管理人 The Hong Kong Underwriter 香港包銷商 Applicants’ declaration 申請人聲明

本人╱吾等同意本申請表格及招股章程的條款及條件 以及申請程序。請參閱本申請表格「填交本申請表格 的效用」一節。

I/We agree to the terms and conditions and application procedures in this Application Form and the Prospectus. Please refer to the “Effect of completing and submitting this Application Form” section of this Application Form.

警告：任何人士僅限作出一次為其利益而進行的認購 申請。請參閱「填交本申請表格的效用」一節最後四 點。

Warning: Only one application may be made for the benefit of any person. Please refer to the last four bullets of “Effect of completing and submitting this Application Form” section.

Please use this form if you want the Hong Kong Offer Shares to be issued in your name 如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

Signed by (all) applicant(s) (all joint applicants must sign): For Broker use此欄供經紀填寫 Lodged by 遞交申請的經紀 由（所有）申請人簽署（所有聯名申請人必須簽署）： Broker No. 經紀號碼 Broker’s Chop 經紀印章 Date: 日期 : ╱ ╱ D 日 M 月 Y 年 Number of Hong Kong Offer Shares applied for (not more than 39,178,000 Shares) Cheque/banker’s cashier order number 支票╱銀行本票號碼 申請香港發售股份數目（不超過 39,178,000 股股份） Name of bank on which cheque/Banker’s cashier order is Total amount 總額 drawn (see “How to make your application” section) 兌現支票 ╱銀行本票的銀行名稱（見「申請手續」一節） HK$ 港元 Name in English (in Block Letters) 英文姓名╱名稱（正楷） Family name or company name 姓氏或公司名稱 Forename(s) 名字 Name in Chinese 中文姓名╱名稱 Family name or company name 姓氏或公司名稱 Forename(s) 名字 Occupation in English 職業（以英文填寫） Hong Kong Identity Card No./Passport No./Hong Kong Business Registration No. (Please delete as appropriate) 香港身份證號碼╱ 護照號碼╱香港商業登記號碼 （請刪除不適用者） Names of all other joint applicants in English (if any) (in Block Letters) Hong Kong Identity Card No./Passport No./Hong Kong Business 所有其他聯名申請人的英文姓名╱名稱（如有）（正楷） Registration No. of all other joint applicants (Please delete as appropriat e ) 所有其他聯名申請人的香港身份證號碼╱護照號 1) 碼╱香港商業登記號碼 （請刪除不適用者） 1） 2) 2) 3) 3) Hong Kong address in English and telephone no. (joint ap p licants should give the address and the telephone number of first-named applicant only) (in Block Letters) 香港地址（以英文填寫）及電話號碼（聯名申請人只須填寫排名首位申請人的地址及電話號碼）（正楷） Telephone No. 電話號碼 For Nominees: You will be treated as applying for your own benefit if you do not complete this section. Please provide an account number or identific a tion code for each (joint) beneficial owner. 由代名人遞交：如 閣下不填寫本欄，是項認購申請 將視作為 閣下利益提出。請填寫每名（聯名）實益擁有人的 賬戶號碼或識別編碼。 ADDRESS LABEL 地址標貼 (Your name(s) and address in Hong Kong in BLOCK letters 請用 正楷 填寫 姓名╱名稱 及香港 地址 ）

For Internal use 此欄供內部使用

Please use this form if you want the Hong Kong Offer Shares to be issued in your name 如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

• (1) An individual must provide his Hong Kong Identity Card number or, if he does not hold a Hong Kong Identity Card, his passport number. A body corporate must provide its Hong Kong Business Registration number. Each joint applicant must provide its or his relevant number. The Hong Kong Identity Card number(s)/passport number(s)/Hong Kong Business Registration number(s) will be transferred to a third party for checking the Application Form’s validity. 個別人士須填寫其香港身份證號碼或（如非香港身份證持有人）護照號碼。法人團體須填寫其香 港商業登記號碼。每名聯名申請人均須提供其相關號碼。該等香港身份證號碼╱護照號碼╱香 港商業登記號碼將轉交第三方以核實申請表格的有效性。

• (2) Part of the Hong Kong Identity Card number/passport number of you or, for joint applicants, the first-named applicant may be printed on your refund cheque (if any). Your banker may require verification of your Hong Kong Identity Card number/passport number before you can cash your refund cheque. 退款支票（如有）上或會印有 閣下或（如屬聯名申請人）排名首位申請人的香港身份證號碼╱護 照號碼的一部分。銀行兌現退款支票前或會要求查證 閣下的香港身份證號碼╱護照號碼。

• (3) If an application is made by an unlisted company and: ‧ the principal business of that company is dealing in securities; and ‧ you exercise statutory control over that company, then the application will be treated as being made for your benefit. 倘若申請人是一家非上市公司，而： ‧ 該公司主要從事證券買賣業務；及

• ‧ 閣下對該公司可行使法定控制權，

• 是項申請將視作為 閣下的利益提出。

• (3) If an application is made by an unlisted company and:

This page is intentionally left blank 此乃白頁 特意留空

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

How to make your application

1. Use the table below to calculate how much you must pay. Your application must be for a minimum of 2,000 Hong Kong Offer Shares and in one of the numbers set out in the table, or your application will be rejected.

1. Use the table below to calculate how much you must pay. Your application must be for a minimum of 2,000 Hong Kong Offer Shares and in one of the numbers set out in the table, or your application will be rejected.	1. Use the table below to calculate how much you must pay. Your application must be for a minimum of 2,000 Hong Kong Offer Shares and in one of the numbers set out in the table, or your application will be rejected.	1. Use the table below to calculate how much you must pay. Your application must be for a minimum of 2,000 Hong Kong Offer Shares and in one of the numbers set out in the table, or your application will be rejected.	1. Use the table below to calculate how much you must pay. Your application must be for a minimum of 2,000 Hong Kong Offer Shares and in one of the numbers set out in the table, or your application will be rejected.
NUMBER OF SHARES THAT MAY BE APPLIED FOR AND PAYMENTS
No. of Hong Kong Amount Offer Shares payable on applied for application	No. of Hong Kong Amount Offer Shares payable on applied for application	No. of Hong Kong Amount Offer Shares payable on applied for application	No. of Hong Kong Amount Offer Shares payable on applied for application
HK$ 2,000 3,939.31 4,000 7,878.60 6,000 11,817.91 8,000 15,757.20 10,000 19,696.51 12,000 23,635.80 14,000 27,575.11 16,000 31,514.40 18,000 35,453.71 20,000 39,393.00 30,000 59,089.51 40,000 78,786.01 50,000 98,482.51	HK$ 60,000 118,179.01 70,000 137,875.52 80,000 157,572.01 90,000 177,268.52 100,000 196,965.02 150,000 295,447.53 200,000 393,930.03 250,000 492,412.54 300,000 590,895.05 350,000 689,377.56 400,000 787,860.06 450,000 886,342.57 500,000 984,825.08	HK$ 600,000 1,181,790.09 700,000 1,378,755.11 800,000 1,575,720.12 900,000 1,772,685.14 1,000,000 1,969,650.15 1,500,000 2,954,475.23 2,000,000 3,939,300.30 2,500,000 4,924,125.38 3,000,000 5,908,950.45 3,500,000 6,893,775.53 4,000,000 7,878,600.60 4,500,000 8,863,425.68 5,000,000 9,848,250.75 e樣	HK$ 6,000,000 11,817,900.90 7,000,000 13,787,551.05 8,000,000 15,757,201.20 9,000,000 17,726,851.35 10,000,000 19,696,501.50 15,000,000 29,544,752.25 20,000,000 39,393,003.00 25,000,000 49,241,253.75 30,000,000 59,089,504.50 35,000,000 68,937,755.25 39,178,000(1) 77,166,953.58 (1) Maximum number of Hong Kong Offer Shares you may apply for.

• 40,000 78,786.01 450,000 886,342.57 4,500,000 8,863,425.68 (1) Maximum number of Hong

• 50,000 98,482.51 500,000 984,825.08 5,000,000 9,848,250.75 Kong Offer Shares you may apply for.

• 1. Complete the form in English (in Block Letters) and sign it. Only written signatures will be accepted (and not by way of personal chop).
• 1. Staple your cheque or banker’s cashier order to the form. Each application for the Hong Kong Offer Shares must be accompanied by either one separate cheque or one separate banker’s cashier order. Your application will be rejected if your cheque or banker’s cashier order does not meet all the following requirements:

• The cheque must: Banker’s cashier order must: ‧ be in Hong Kong dollars; ‧ not be post-dated; ‧ be made payable to “ BANK OF CHINA (HONG KONG) NOMINEES LIMITED – MABPHARM PUBLIC OFFER ”;

• ‧ be crossed “Account Payee Only”; ‧ ‧ be drawn on your Hong Kong dollar bank be issued by a licensed bank in Hong Kong, and account in Hong Kong; and have your name certified on the back by a person

• ‧ show your account name, which must either be authorised by the bank. The name on the banker’s pre-printed on the cheque, or be endorsed on the cashier order must correspond with your name. back by a person authorised by the bank. This If it is a joint application, the name on the back account name must correspond with your name. of the banker’s cashier order must be the same as If it is a joint application, the account name must the first-named applicant’s name. be the same as the first-named applicant’s name.

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

1. Tear off the Application Form, fold it once and lodge your completed Application Form (with cheque or banker’s cashier order attached) to one of the collection boxes at any of the following branches of the receiving banks: Bank of China (Hong Kong) Limited District Branch name Address Hong Kong Island Des Voeux Road West Branch 111-119 Des Voeux Road West, Hong Kong Central District (Wing On B/F-2/F, Wing On House, 71 Des Voeux Road Central, House) Branch Hong Kong Kowloon Whampoa Garden Branch Shop G8B, Site 1, Whampoa Garden, Hung Hom, Kowloon Jordan Road Branch 1/F, Sino Cheer Plaza, 23-29 Jordan Road, Kowloon New Territories Tai Po Branch 68-70 Po Heung Street, Tai Po Market, New Territories Yuen Long (Hang Fat 8-18 Castle Peak Road, Yuen Long, New Territories Mansion) Branch CMB Wing Lung Bank Limited District Branch name Address Hong Kong Island Head Office 45 D e s Voeux Road Central Kennedy Town Branch 28 Catchick Street Aberdeen Branch 201 Aberdeen Main Road Kowloon Mongkok Branch B/F Wing Lung Bank Centre, 636 Nathan Road San Po Kong Branch 8 Shung Ling Street 5. Your Application Form can be lodged at these times: — Monday, May 20, 2019 9:00 a.m. to 5:00 p.m. Tuesday, May 21, 2019 — 9:00 a.m. to 5:00 p.m. — Wendnesday, May 22, 2019 9:00 a.m. to 5:00 p.m. — Thursday, May 23, 2019 9:00 a.m. to 5:00 p.m Friday, May 24, 2019 — 9:00 a.m. to 12:00 noon 6. The latest time for lodging your application is 12:00 noon on Friday, May 24, 2019. The application lists will be open between 11:45 a.m. and 12:00 noon on that day, subject only to the weather conditions, as described in the section headed “How to Apply for Hong Kong Offer Shares – 10. Effect of Bad Weather on the Opening of the Application Lists” in the Prospectus.

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

申請手續

1. 請使用下表計算 閣下應付的款項。 閣下申請認購的股數須至少為 2,000 股香港發售股份，並 為下表所列的其中一個數目，否則 閣下的申請將不獲受理。

可供申請認購股份數目及應繳款項 申請認購的 申請認購的 申請認購的 申請認購的 香港發售 申請時 香港發售 申請時 香港發售 申請時 香港發售 申請時 股份數目 應繳款項 股份數目 應繳款項 股份數目 應繳款項 股份數目 應繳款項 港元 港元 港元 港元 2,000 3,939.31 60,000 118,179.01 600,000 1,181,790.09 6,000,000 11,817,900.90 4,000 7,878.60 70,000 137,875.52 700,000 1,378,755.11 7,000,000 13,787,551.05 6,000 11,817.91 80,000 157,572.01 800,000 1,575,720.12 8,000,000 15,757,201.20 8,000 15,757.20 90,000 177,268.52 900,000 1,772,685.14 9,000,000 17,726,851.35 10,000 19,696.51 100,000 196,965.02 1,000,000 1,969,650.15 10,000,000 19,696,501.50 12,000 23,635.80 150,000 295,447.53 1,500,000 2,954,475.23 15,000,000 29,544,752.25 14,000 27,575.11 200,000 393,930.03 2,000,000 3,939,300.30 20,000,000 39,393,003.00 16,000 31,514.40 250,000 492,412.54 2,500,000 4,924,125.38 25,000,000 49,241,253.75 18,000 35,453.71 300,000 590,895.05 3,000,000 5,908,950.45 30,000,000 59,089,504.50 20,000 39,393.00 350,000 689,377.56 3,500,000 6,893,775.53 35,000,000 68,937,755.25 30,000 59,089.51 400,000 787,860.06 4,000,000 7,878,600.60 39,178,000(1) 77,166,953.58 40,000 78,786.01 450,000 886,342.57 4,500,000 8,863,425.68 (1) 閣下可申請認購的香港發 售股份最高數目。 50,000 98,482.51 500,000 984,825.08 5,000,000 9,848,250.75 2. 以英文（正楷）填妥及簽署申請表格。僅接納親筆簽名（不得以個人印鑑代替）。 3. 閣下須將支票或銀行本票釘於表格上。每份香港發售股份申請須隨附一張獨立開出支票或一張 獨立開出銀行本票。支票或銀行本票必須符合以下所有規定，否則 閣下的申請將不獲受理： 支票須： 銀行本票須： ‧ 為港元； ‧ 不得為期票； ‧ 註明抬頭人為「中國銀行（香港）代理人有限公司－邁博藥業公開發售」； ‧ 劃線註明「只准入抬頭人賬戶」； ‧ 從 閣下在香港的港元銀行賬戶中開出；及 ‧ 顯示 閣下的賬戶名稱，而該賬戶名稱須已 預印在支票上，或由有關銀行授權的人士在 支票背書。該賬戶名稱須與 閣下的姓名╱ ‧ 由香港持牌銀行開出，並由有關銀行授權的 人士在銀行本票背面簽署核證 閣下的姓名 ╱名稱。銀行本票所示姓名╱名稱須與 閣 下的姓名╱名稱相同。如屬聯名申請，則銀 Sample樣版	可供申請認購股份數目及應繳款項 申請認購的 申請認購的 申請認購的 申請認購的 香港發售 申請時 香港發售 申請時 香港發售 申請時 香港發售 申請時 股份數目 應繳款項 股份數目 應繳款項 股份數目 應繳款項 股份數目 應繳款項 港元 港元 港元 港元 2,000 3,939.31 60,000 118,179.01 600,000 1,181,790.09 6,000,000 11,817,900.90 4,000 7,878.60 70,000 137,875.52 700,000 1,378,755.11 7,000,000 13,787,551.05 6,000 11,817.91 80,000 157,572.01 800,000 1,575,720.12 8,000,000 15,757,201.20 8,000 15,757.20 90,000 177,268.52 900,000 1,772,685.14 9,000,000 17,726,851.35 10,000 19,696.51 100,000 196,965.02 1,000,000 1,969,650.15 10,000,000 19,696,501.50 12,000 23,635.80 150,000 295,447.53 1,500,000 2,954,475.23 15,000,000 29,544,752.25 14,000 27,575.11 200,000 393,930.03 2,000,000 3,939,300.30 20,000,000 39,393,003.00 16,000 31,514.40 250,000 492,412.54 2,500,000 4,924,125.38 25,000,000 49,241,253.75 18,000 35,453.71 300,000 590,895.05 3,000,000 5,908,950.45 30,000,000 59,089,504.50 20,000 39,393.00 350,000 689,377.56 3,500,000 6,893,775.53 35,000,000 68,937,755.25 30,000 59,089.51 400,000 787,860.06 4,000,000 7,878,600.60 39,178,000(1) 77,166,953.58 40,000 78,786.01 450,000 886,342.57 4,500,000 8,863,425.68 (1) 閣下可申請認購的香港發 售股份最高數目。 50,000 98,482.51 500,000 984,825.08 5,000,000 9,848,250.75 2. 以英文（正楷）填妥及簽署申請表格。僅接納親筆簽名（不得以個人印鑑代替）。 3. 閣下須將支票或銀行本票釘於表格上。每份香港發售股份申請須隨附一張獨立開出支票或一張 獨立開出銀行本票。支票或銀行本票必須符合以下所有規定，否則 閣下的申請將不獲受理： 支票須： 銀行本票須： ‧ 為港元； ‧ 不得為期票； ‧ 註明抬頭人為「中國銀行（香港）代理人有限公司－邁博藥業公開發售」； ‧ 劃線註明「只准入抬頭人賬戶」； ‧ 從 閣下在香港的港元銀行賬戶中開出；及 ‧ 顯示 閣下的賬戶名稱，而該賬戶名稱須已 預印在支票上，或由有關銀行授權的人士在 支票背書。該賬戶名稱須與 閣下的姓名╱ ‧ 由香港持牌銀行開出，並由有關銀行授權的 人士在銀行本票背面簽署核證 閣下的姓名 ╱名稱。銀行本票所示姓名╱名稱須與 閣 下的姓名╱名稱相同。如屬聯名申請，則銀 Sample樣版
名稱相同。如屬聯名申請，則賬戶名稱須與 行本票背面所示姓名╱名稱須與排名首位申
排名首位申請人的姓名╱名稱相同。 請人的姓名╱名稱相同。

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

1. 請撕下申請表格，對摺一次，然後將填妥的申請表格（連同支票或銀行本票）投入收款銀行的下 列任何一家分行的收集箱： 中國銀行（香港）有限公司 地區 分行名稱 地址 香港島 德輔道西分行 香港德輔道西 111-119 號 中環永安集團大廈分行 香港德輔道中 71 號永安集團大廈地庫至二樓 九龍 黃埔花園分行 九龍紅磡黃埔花園第一期商場 G8B 號 佐敦道分行 九龍佐敦道 23-29 號新寶廣場一樓 新界 大埔分行 新界大埔墟寶鄉街 68-70 號 元朗恒發樓分行 新界元朗青山公路 8-18 號 招商永隆銀行有限公司 地區 分行名稱 地址 香港島 總行 德輔道中 45 號 堅尼地城分行 吉席街 28 號 香港仔分行 香港仔大道 201 號 九龍 旺角分行 彌敦道 636 號招商永隆銀行中心地庫 新蒲崗分行 崇齡街 8 號 5. 閣下可於下列時間遞交申請表格： 2019 年 5 月 20 日（星期一）－上午九時正至下午五時正 2019 年 5 月 21 日（星期二）－上午九時正至下午五時正 2019 年 5 月 22 日（星期三）－上午九時正至下午五時正 2019 年 5 月 23 日（星期四）－上午九時正至下午五時正 2019 年 5 月 24 日（星期五）－上午九時正至中午十二時正 6. 截止遞交申請的時間為 2019 年 5 月 24 日（星期五）中午十二時正。開始登記申請的時間為當日上 午十一時四十五分至中午十二時正，唯一會影響此時間的變化因素為當日的天氣情況（詳見招股 章程「如何申請香港發售股份－10. 惡劣天氣對開始辦理申請登記的影響」一節）。

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

==> picture [54 x 54] intentionally omitted <==

Mabpharm Limited 邁博藥業有限公司 (Incorporated in the Cayman Islands with limited liability) GLOBAL OFFERING Conditions of your application other parties involved in the Global Offering is or will be liable for any information and representations not in the Prospectus (and any A. Who can apply supplement to it); 1. You and any person(s) for whose benefit you are applying must be ‧ undertake and confirm that you or the person(s) for whose benefit 18 years of age or older and must have a Hong Kong address. you have made the application have not applied for or taken up, 2. If you are a firm, the application must be in the individual or indicated an interest for, and will not apply for or take up, or members’ names. indicate an interest for, any Offer Shares under the International 3. The number of joint applicants may not exceed 4. Offering nor participated in the International Offering; 4. If you are a body corporate, the application must be signed by a ‧ agree to disclose to the Company, the Hong Kong Share Registrar, duly authorised officer, who must state his representative capacity, the receiving banks, the Sole Global Coordinator, the Sole Sponsor, and stamped with your corporation’s chop. the Sole Bookrunner, the Underwriters and/or their respective 5. You must be outside the United States, not be a United States advisers and agents any personal data which they may require Person (as defined in Regulation S under the U.S. Securities Act) about you and the person(s) for whose benefit you have made the and not be a legal or natural person of the PRC. application; 6. Unless permitted by the Listing Rules, you cannot apply for any ‧ if the laws of any place outside Hong Kong apply to your Hong Kong Offer Shares if you: application, agree and warrant that you have complied with all ‧ are an existing beneficial owner of Shares in the Company such laws and none of the Company, the Sole Global Coordinator, and/or any of its subsidiaries; the Sole Sponsor, the Sole Bookrunner and the Underwriters nor ‧ are a Director or chief executive officer of the Company and/ any of their respective officers or advisers will breach any law or any of its subsidiaries; outside Hong Kong as a result of the acceptance of your offer to ‧ are a connected person (as defined in the Listing Rules) purchase, or any action arising from your rights and obligations of the Company or will become a connected person of under the terms and conditions contained in the Prospectus and this the Company immediately upon completion of the Global Application Form; Offering; ‧ agr e e that once your application has been accepted, you may not ‧ are an associate (as defined in the Listing Rules) of any of rescind it because of an innocent misrepresentation; the above; or ‧ agree that your application will be governed by the laws of Hong ‧ have been allocated or have applied for or indicated an Kong; interest in any International Offer Shares or otherwise ‧ represent, warrant and undertake that (i) you understand that the participate in the International Offering. Hong Kong Offer Shares have not been and will not be registered under the U.S. Securities Act; and (ii) you and any person for B. If you are a nominee whose benefit you are applying for the Hong Kong Offer Shares You, as a nominee, may make more than one application for the Hong are outside the United States (as defined in Regulation S) or are a Kong Offer Shares by: (i) giving electronic instructions to HKSCC via person described in paragraph (h)(3) of Rule 902 of Regulation S; Central Clearing and Settlement System (“CCASS”) (if you are a CCASS ‧ warrant that the information you have provided is true and accurate; Participant); or (ii) using a WHITE or YELLOW Application Form, and ‧ agree to accept the Hong Kong Offer Shares applied for, or any lodge more than one application in your own name on behalf of different lesser number allocated to you under the application; beneficial owners. ‧ authorise (i) the Company to place your name(s) on the Company’s register of members as the holder(s) of any Hong Kong Offer C. Effect of completing and submitting this Application Form Shares allocated to you and such other registers as required under By completing and submitting this Application Form, you (and if you are the Memorandum and Articles of Association of the Company, and joint applicants, each of you jointly and severally) for yourself or as an (ii) the Company and/or its agents to send any share certificate(s) agent or a nominee on behalf of each person for whom you act: ‧ undertake to execute all relevant documents and instruct and and/or any refund cheque(s) to you or the first-named applicant for joint application by ordinary post at your own risk to the address authorise the Company a nd/or the Sole Global Coordinator (or their stated on the application, unless you have fulfilled the criteria agents or nominees), as agents of the Company, to execute any mentioned in “Personal Collection” section in the Prospectus to documents for you and to do on your behalf all things necessary to collect the share certificate(s) and/or refund cheque(s) in person; register any Hong Kong Offer Shares allocated to you in your name ‧ understand that, in accordance with Guidance Letter HKExGL91-18 as required by the Articles; ‧ agree to comply with the Cayman Islands Law, Companies Ordinance, issued by the Stock Exchange where the International Offer Shares are undersubscribed and the Hong Kong Offer Shares the Companies (Winding Up and Miscellaneous Provisions) Ordinance are oversubscribed irrespective of the number of times, up to and the Memorandum and Articles of the Company; ‧ confirm that you have read the terms and conditions and application 78,358,000 Shares may be reallocated to the Hong Kong Public Offering from the International Offering, so that the total number procedures set out in the Prospectus and in this Application Form of the Shares available under the Hong Kong Public Offer will and agree to be bound by them;

• ‧ authorise (i) the Company to place your name(s) on the Company’s register of members as the holder(s) of any Hong Kong Offer Shares allocated to you and such other registers as required under the Memorandum and Articles of Association of the Company, and (ii) the Company and/or its agents to send any share certificate(s) and/or any refund cheque(s) to you or the first-named applicant for joint application by ordinary post at your own risk to the address stated on the application, unless you have fulfilled the criteria mentioned in “Personal Collection” section in the Prospectus to collect the share certificate(s) and/or refund cheque(s) in person;

• ‧ understand that, in accordance with Guidance Letter HKExGL91-18 issued by the Stock Exchange where the International Offer Shares are undersubscribed and the Hong Kong Offer Shares are oversubscribed irrespective of the number of times, up to 78,358,000 Shares may be reallocated to the Hong Kong Public Offering from the International Offering, so that the total number of the Shares available under the Hong Kong Public Offer will be increased to 156,716,000 Shares, representing 20% of the number of the Offer Shares initially available under the Global Offering (before any exercise of the Over-allotment Option), and the final Offer Price shall be fixed at the low-end of the indicative Offer Price range (i.e. HK$1.50 per Offer Share) as stated in the Prospectus. Further details of the reallocation are stated in the paragraph headed “Structure of the Global Offering — Reallocation and clawback” of the Prospectus;

• ‧ confirm that you have received and read the Prospectus and have only relied on the information and representations contained in the Prospectus in making your application and will not rely on any other information or representations except those in any supplement to the Prospectus;

• ‧ confirm that you are aware of the restrictions on the Global Offering in the Prospectus;

• ‧ agree that none of the Company, the Sole Global Coordinator, the Sole Sponsor, the Sole Bookrunner, the Underwriters, their respective directors, officers, employees, partners, agents, advisers and any

• ‧ declare and represent that this is the only application made and the only application intended by you to be made to benefit you or the person for whose benefit you are applying;

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

If you do not collect your share certificate(s) and/or refund cheque(s) personally within the time specified for collection, they will be dispatched promptly to the address as specified on this Application Form by ordinary post at your own risk.

‧ understand that the Company, the Directors, and the Sole Global If you do not collect your share certificate(s) and/or refund cheque(s) Coordinator will rely on your declarations and representations in personally within the time specified for collection, they will be dispatched deciding whether or not to make any allotment of any of the Hong promptly to the address as specified on this Application Form by ordinary Kong Offer Shares to you and that you may be prosecuted for post at your own risk. making a false declaration; ‧ (if the application is made for your own benefit) warrant that no If you apply for less than 1,000,000 Hong Kong Offer Shares, your refund other application has been or will be made for your benefit on a cheque(s) and/or share certificate(s) will be sent to the address on the relevant WHITE or YELLOW Application Form or by giving electronic Application Form on or before Thursday, May 30, 2019, by ordinary post and application instructions to HKSCC or to the White Form eIPO at your own risk. Service Provider by you or by any one as your agent or by any other person; and Refund of your money ‧ (if you are making the application as an agent for the benefit of If an application is rejected, not accepted or accepted in part only, or if the another person) warrant that (i) no other application has been or Offer Price as finally determined is less than the maximum Offer Price of will be made by you as agent for or for the benefit of that person or HK$1.95 per Offer Share (excluding brokerage, SFC transaction levy and by that person or by any other person as agent for that person on a the Stock Exchange trading fee thereon), or if the conditions of the Hong WHITE or YELLOW Application Form or by giving electronic Kong Public Offering are not fulfilled in accordance with “Structure of the application instructions to HKSCC and (ii) you have due authority Global Offering – Conditions of the Global Offering” in the Prospectus to sign the Application Form or give electronic application or if any application is revoked, the application monies, or the appropriate instructions on behalf of that other person as their agent. portion thereof, together with the related brokerage, SFC transaction levy D. Power of attorney and the Stock Exchange trading fee, will be refunded, without interest or If your application is made through an authorised attorney, the Company the cheque or banker’s cashier order will not be cleared. and the Sole Global Coordinator may accept or reject your application at Any refund of the application monies will be made on Thursday, May 30, its discretion, and on any conditions it thinks fit, including evidence of the 2019. attorney’s authority. Determination of Offer Price and Allocation of Hong Kong Offer The refund procedures are stated in the section headed “How to Apply for Shares Hong Kong Offer Shares – 14. Despatch/Collection of share certificates The Offer Price is expected to be fixed on or around Friday, May 24, 2019. and refund monies” in the Prospectus. Applicants are required to pay the maximum Offer Price of HK$1.95 for Application by HKSCC Nominees Limited (“HKSCC Nominees”) each Offer Share together with brokerage fee of 1%, SFC transaction levy of 0.0027% and Stock Exchange trading fee of 0.005%. If the Offer Price Where this Application Form is signed by HKSCC Nominees on behalf is not agreed between the Company and the Sole Global Coordinator (for of persons who have given electronic application instructions to apply itself and on behalf of the Underwriters) on or before Sunday, May 26, for the Hong Kong Offer Shares, the provisions of this Application Form 2019, the Global Offering will not proceed and will lapse. which are inconsistent with those set out in the Prospectus shall not apply and provisions in the Prospectus shall prevail. Applications for Hong Kong Offer Shares will not be processed and no allotment of any Hong Kong Offer Shares will be made until the application Without limiting the generality of this paragraph, the following sections lists close. of this Application Form are inapplicable where this form is signed by If the Company decides to set the Offer Price after making a HKSCC Nominees: Downward Offer Price Adjustment (a reduction of up to 10% ‧ “Applicants’ declaration” on the first page; below HK$1.50), the Company will separately announce the final ‧ “Warning” on the first page; Offer Price no later than Thursday, May 30, 2019 on the website ‧ “If you are a nominee”; of the Stock Exchange at www.hkexnews.hk and the Company’s ‧ All representations and warranties under the “Effect of completing website at www.mabpharm.cn . and submitting this Application Form” section, except the first one regarding registration of Hong Kong Offer Shares in the applicant’s Irrespective of whether a Downward Offer Price Adjustment is made, name and the signing of documents to enable the applicant to be Company expects to announce the final Offer Price, the indication of the level of interest in the International Offering, the level of applications under registered as the holder of the Hong Kong Offer Shares; the Hong Kong Public Offering and the basis of allocation of the Hong ‧ “If your application for Hong Kong Offer Shares is successful (in Kong Offer Shares on Thursday, May 30, 2019 in South China Morning whole or in part)”; and Post (in English), the Hong Kong Economic Times (in Chinese), the website ‧ “Refund of your money”. of the Stock Exchange at www.hkexnews.hk and the Company’s website at www.mabpharm.cn . Results of allocations and the Hong Kong identity Results of allocations and the Hong Kong identity The following sub-sections in the section headed “How to Apply for Hong Kong Offer Shares” in the Prospectus are inapplicable where this card/passport/Hong Kong business registration numbers of successful applicants (where applicable) under the Hong Kong Public Offering will be form is signed by HKSCC Nominees: available at the times and dates and in the manner described in the section ‧ “8. How many applications can you make”; and headed “How to Apply for Hong Kong Offer Shares – 11. Publication of ‧ “12. Circumstances in which you will not be allotted Hong Kong Results” in the Prospectus. Offer Shares”. If your application for Hong Kong Offer Shares is successful (in Effect of the Information You Give to Computershare Hong Kong whole or in part) Investor Services Limited If you apply for 1,000,000 or more Hong Kong Offer Shares and have Computershare Hong Kong Investor Services Limited and its provided all information required by your Application Form, you may related bodies’ corporate, directors, officers, employees and agents collect your share certificate(s) and/or refund cheque(s) in person from our (“ Representatives ”) expressly disclaim and exclude to the maximum Hong Kong Share Registrar: Computershare Hong Kong Investor Services extent permitted by law any liability for any loss or damage suffered or Limited at Shops 1712-1716, Hopewell Centre, 183 Queen’s Road East, incurred by the applicant or any other person or entity however caused Wanchai, Hong Kong, from 9:00 a.m. to 1:00 p.m. on Thursday, May 30, relating in any way to, or connected with, any information provided by or 2019 or such other date as notified by us in the newspapers. on behalf of the applicant on or in connection with this document or any If you are an individual who is eligible for personal collection, you must services provided hereunder, or any other written or oral communication not authorise any other person to collect for you. If you are a corporate provided by or on behalf of the applicant in connection with this applicant which is eligible for personal collection, your authorised document or any services provided hereunder. This includes, without representative must bear a letter of authorisation from your corporation limitation, any errors or omissions in such information however caused, or stamped with your corporation’s chop. Both individuals and authorised the Representatives or any other person or entity placing any reliance on representatives must produce, at the time of collection, evidence of such information or any documentation, image, recording or reproduction identity acceptable to our Hong Kong Share Registrar. of such information, or its accuracy, completeness, currency or reliability.

• ‧ (if you are making the application as an agent for the benefit of another person) warrant that (i) no other application has been or will be made by you as agent for or for the benefit of that person or by that person or by any other person as agent for that person on a WHITE or YELLOW Application Form or by giving electronic application instructions to HKSCC and (ii) you have due authority to sign the Application Form or give electronic application instructions on behalf of that other person as their agent.

D. Power of attorney

If your application is made through an authorised attorney, the Company and the Sole Global Coordinator may accept or reject your application at its discretion, and on any conditions it thinks fit, including evidence of the attorney’s authority.

Applications for Hong Kong Offer Shares will not be processed and no allotment of any Hong Kong Offer Shares will be made until the application Without limiting the generality of this paragraph, the following sections lists close. of this Application Form are inapplicable where this form is signed by If the Company decides to set the Offer Price after making a HKSCC Nominees: Downward Offer Price Adjustment (a reduction of up to 10% ‧ “Applicants’ declaration” on the first page; below HK$1.50), the Company will separately announce the final ‧ “Warning” on the first page; Offer Price no later than Thursday, May 30, 2019 on the website ‧ “If you are a nominee”; of the Stock Exchange at www.hkexnews.hk and the Company’s ‧ All representations and warranties under the “Effect of completing website at www.mabpharm.cn . and submitting this Application Form” section, except the first one regarding registration of Hong Kong Offer Shares in the applicant’s Irrespective of whether a Downward Offer Price Adjustment is made, name and the signing of documents to enable the applicant to be Company expects to announce the final Offer Price, the indication of the level of interest in the International Offering, the level of applications under registered as the holder of the Hong Kong Offer Shares; the Hong Kong Public Offering and the basis of allocation of the Hong ‧ “If your application for Hong Kong Offer Shares is successful (in whole or in part)”; and

Irrespective of whether a Downward Offer Price Adjustment is made, Company expects to announce the final Offer Price, the indication of the level of interest in the International Offering, the level of applications under the Hong Kong Public Offering and the basis of allocation of the Hong ‧ Kong Offer Shares on Thursday, May 30, 2019 in South China Morning Post (in English), the Hong Kong Economic Times (in Chinese), the website ‧ of the Stock Exchange at www.hkexnews.hk and the Company’s website at www.mabpharm.cn . Results of allocations and the Hong Kong identity Results of allocations and the Hong Kong identity card/passport/Hong Kong business registration numbers of successful applicants (where applicable) under the Hong Kong Public Offering will be available at the times and dates and in the manner described in the section ‧ headed “How to Apply for Hong Kong Offer Shares – 11. Publication of ‧ Results” in the Prospectus.

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格 Mabpharm Limited 邁博藥業有限公司 （於開曼群島註冊成立的有限公司） 全球發售 申請條件 ‧ 同意本公司、獨家全球協調人、獨家保薦人、獨家賬 簿管理人、包銷商、彼等各自的董事、高級職員、僱 甲 . 可提出申請的人士 員、合夥人、代理、顧問及參與全球發售的任何其他 1. 閣下及 閣下為其利益提出申請的任何人士必須年滿 各方目前或將來均毋須對並非載於招股章程（及其任 18 歲並有香港地址。 何補充文件）的任何資料及陳述負責； 2. 如 閣下為商號，申請須以個別成員名義提出。 ‧ 承諾及確認 閣下或 閣下為其利益提出申請的人士 3. 聯名申請人不得超過四名。 並無申請或接納或表示有意認購（且將不會申請或接 4. 如 閣下為法人團體，申請須由獲正式授權的高級職 納或表示有意認購）國際發售項下的任何發售股份， 員簽署，並註明其代表身份及加蓋公司印鑑。 亦無參與國際發售； 5. 閣下必須身處美國境外，並非美籍人士（定義見美國 ‧ 同意向本公司、香港證券登記處、收款銀行、獨家全 證券法 S 規例），亦非中國法人或自然人。 球協調人、獨家保薦人、獨家賬簿管理人、包銷商及 6. 除上市規則批准外，下列人士概不得申請認購任何香 ╱或彼等各自的顧問及代理披露彼等所要求有關 閣 港發售股份： ‧ 下及 閣下為其利益提出申請的人士的任何個人資 本公司及╱或其任何附屬公司股份的現有實益 料； 擁有人； ‧ ‧ 若香港境外任何地方的法律適用於 閣下的申請，則 本公司及╱或其任何附屬公司的董事或行政總 同意及保證 閣下已遵守所有有關法律，且本公司、 裁； ‧ 本公司關連人士（定義見上市規則）或緊隨全球 獨家全球協調人、獨家保薦人、獨家賬簿管理人及包 銷商以及彼等各自的任何高級職員或顧問概不會因接 發售完成後將成為本公司關連人士的人士； ‧ 上述任何人士的聯繫人（定義見上市規則）；或 納 閣下的購買要約，或 閣下在招股章程及本申請 ‧ 表格所載條款及條件下的權利及責任所引致的任何行 已獲分配或已申請或表示有意申請任何國際發 動，而違反香港境外的任何法律； 售股份或以其他方式參與國際發售的人士。 ‧ 同意 閣下的申請一經接納，概不得因無意的失實陳 乙 . 如 閣下為代名人 述而撤回； 閣下可以代名人身份提交超過一份香港發售股份申請，方 ‧ 同意 閣下的申請將受香港法例規管； 法是：(i) 透過中央結算及交收系統（「中央結算系統」）向香 ‧ 聲明、保證及承諾：(i) 閣下明白香港發售股份不曾 港結算發出電子指示（如 閣下為中央結算系統參與者）； 亦不會根據美國證券法登記；及 (ii) 閣下及 閣下 或 (ii) 使用 白色 或 黃色 申請表格，以自身名義代表不同的 為其利益申請香港發售股份的任何人士均身處美國境 實益擁有人提交超過一份申請。 外（定義見 S 規例），或均屬 S 規例第 902 條第 (h)(3) 段所述人士； 丙 . 填交本申請表格的效用 ‧ 保證 閣下提供的資料真實及準確； 閣下填妥並遞交本申請表格，即表示 閣下（如屬聯名申 ‧ 同意接納所申請數目或分配予 閣下但數目少於申請 請人，即各人共同及個別）代表 閣下本身，或作為 閣 數目的香港發售股份； 下代其行事的每位人士的代理或代名人： ‧ ‧ 授權 (i) 本公司將 閣下的姓名╱名稱列入本公司股東 承諾簽署所有相關文件，並指示及授權本公司及╱或 名冊及本公司組織章程大綱及細則規定的其他名冊， 獨家全球協調人（或彼等的代理或代名人）作為本公 作為 閣下獲分配的任何香港發售股份的持有人， 司的代理，按細則的規定代 閣下簽署任何文件並代 及 (ii) 本公司及╱或其代理以普通郵遞方式按申請所 表 閣下處理一切必要事宜，以將 閣下獲配發的任 示地址向 閣下或聯名申請的排名首位申請人寄發 何香港發售股份以 閣下的名義登記； ‧ 任何股票及╱或退款支票，郵誤風險由 閣下承擔， 同意遵守開曼群島法律、公司條例、公司（清盤及雜 惟 閣下符合招股章程「親身領取」所述標準親身領取 項條文）條例及本公司大綱及細則； 股票及╱或退款支票則除外；

• ‧ 確認 閣下已細閱招股章程及本申請表格所載的條款 及條件以及申請程序，並同意受其約束；

• ‧ 明白根據聯交所發佈的指引函 HKExGL91-18，倘國 際發售股份認購不足而香港發售股份獲超額認購（不 論倍數如何），最多 78,358,000 股發售股份可自國際 發售重新分配至香港公開發售，故香港公開發售可供 認購的股份總數將增至 156,716,000 股股份，相當於

• ‧ 確認 閣下已接獲並細閱招股章程，且提出申請時僅 依賴招股章程所載資料及陳述，而不會依賴任何其他 資料或陳述（招股章程任何補充文件所載者除外）；

• ‧ 確認 閣下知悉招股章程內有關全球發售的限制；

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

如 閣下為個人申請人並合資格親身領取， 閣下不得授 權任何其他人士代領。如 閣下為公司申請人並合資格派 人領取， 閣下的授權代表須攜同加蓋公司印鑑的授權書領 取。個人申請人及授權代表於領取股票時均須出示我們的 香港證券登記處接納的身份證明文件。

全球發售初步可供認購發售股份數目的 20%（超額配 如 閣下為個人申請人並合資格親身領取， 閣下不得授 股權獲行使前），而最終發售價須定為招股章程所述 權任何其他人士代領。如 閣下為公司申請人並合資格派 指標發售價範圍的下限（即每股發售股份 1.50 港元）。 人領取， 閣下的授權代表須攜同加蓋公司印鑑的授權書領 重新分配的詳情載於招股章程「全球發售架構－重新 取。個人申請人及授權代表於領取股票時均須出示我們的 香港證券登記處接納的身份證明文件。 分配及回撥」一段； ‧ 聲明及表示此乃 閣下為本身或 閣下為其利益提出 如 閣下並無在指定領取時間內親身領取股票及╱或退款 支票，有關股票及╱或退款支票將立刻以普通郵遞方式寄 申請的人士所提出及擬提出的唯一申請； 往本申請表格所示地址，郵誤風險由 閣下承擔。 ‧ 明白本公司、董事及獨家全球協調人將依賴 閣下的 如 閣下申請認購 1,000,000 股以下香港發售股份， 閣下 聲明及陳述而決定是否向 閣下配發任何香港發售股 的退款支票及╱或股票將於 2019 年 5 月 30 日（星期四）或之 份， 閣下如作出虛假聲明，可能會被檢控； 前以普通郵遞方式寄往相關申請表格所示地址，郵誤風險 ‧ （倘申請為 閣下本身的利益提出）保證 閣下或作 由閣下承擔。 為 閣下代理的任何人士或任何其他人士不曾亦不會 退回款項 為 閣下的利益以 白色 或 黃色 申請表格或向香港結算 倘申請遭拒絕、不獲接納或僅部分獲接納，或最終釐定的 或 白表 eIPO 服務供應商發出 電子認購指示 而提出其 發售價低於最高發售價每股發售股份 1.95 港元（不包括有 他申請；及 關的經紀佣金、證監會交易徵費及聯交所交易費），或香港 ‧ （倘 閣下作為代理為另一人士的利益提出申請）保證 公開發售的條件並無按照招股章程「全球發售的架構－全球 (i) 閣下（作為代理或為該人士利益）或該人士或任何 發售的條件」一節所述者達成，又或任何申請遭撤回，申請 其他作為該人士代理的人士不曾亦不會以 白色 或 黃色 股款或其中適當部分連同相關經紀佣金、證監會交易徵費 申請表格或向香港結算發出 電子認購指示 而提出其他 及聯交所交易費將不計利息退回或不將有關支票或銀行本 申請；及 (ii) 閣下獲正式授權作為該其他人士的代 票過戶。 。 理代為簽署本申請表格或發出 電子認購指示 任何退回申請股款將於 2019 年 5 月 30 日（星期四）作出。 有關退款程序載於招股章程「如何申請香港發售股份－ 丁 . 授權書 14. 發送╱領取股票及退回股款」一節。 如 閣下透過獲授權人士提出申請，本公司及獨家全球協 調人可按其認為合適的任何條件（包括出示獲授權人士的授 香港中央結算（代理人）有限公司（「香港結算代理人」）提出 權證明）酌情接納或拒絕 閣下的申請。 的申請 如本申請表格由香港結算代理人代表發出 電子認購指示 申 釐定發售價及分配香港發售股份 請香港發售股份的人士簽署，本申請表格與招股章程所載 預期發售價將於 2019 年 5 月 24 日（星期五）或前後釐定。申 不符的條文將不適用，且以招股章程所述者為準。 請人須繳付每股發售股份 1.95 港元的最高發售價，另加 1% 在不限制此段一般應用的前提下，本申請表格的以下部分 經紀佣金、0.0027% 證監會交易徵費及 0.005% 聯交所交易 在香港結算代理人作本表格簽署人的情況下並不適用： 費。倘本公司及獨家全球協調人（為其本身及代表包銷商） ‧ 第一頁的「申請人聲明」； 並無於 2019 年 5 月 26 日（星期日）或之前協定發售價，則全 ‧ 第一頁的「警告」； 球發售將不會進行並將告失效。 ‧ 「如 閣下為代名人」； 截止登記申請前概不處理香港發售股份的申請或配發任何 ‧ 「填交本申請表格的效用」一節項下的所有陳述及保 香港發售股份。 證，惟首項有關以申請人名義登記香港發售股份及簽 倘本公司決定於下調發售價後釐定發售價（最多下調至 1.50 署使申請人登記成為香港發售股份持有人的文件除 港元以下 10%），則本公司將在不遲於 2019 年 5 月 30 日（星 外； 期四）於聯交所網站 www.hkexnews.hk 及本公司網站 www. ‧ 「如 閣下成功申請認購香港發售股份（全部或部 mabpharm.cn 上另行公佈最終發售價。 分）」；及 不論是否下調發售價，本公司預期於 2019 年 5 月 30 日 ‧ 「退回款項」。 招股章程「如何申請香港發售股份」一節的以下分節在香港 （星期四）在《南華早報》（以英文）及《香港經濟日報》（以中 結算代理人作本表格簽署人的情況下並不適用： 文）、聯交所網站 www.hkexnews.hk 及本公司網站 www. ‧ 「8. 閣下可提交的申請數目」；及 mabpharm.cn 公佈最終發售價、國際發售踴躍程度、香港 ‧ 「12. 閣下不獲配發香港發售股份的情況」。 公開發售申請水平及香港發售股份分配基準。香港公開發 閣下提供給香港中央證券登記有限公司的資訊的有關影響 售的分配結果以及根據香港公開發售成功申請人的香港身 香港中央證券登記有限公司和其關聯法人團體、董事、高 份證號碼╱護照號碼╱香港商業登記號碼（如適用）亦同於 級職員、僱員及代理（「 代表 」）在法律所容許的最大限度 招股章程「如何申請香港發售股份－11. 公佈結果」一節所述 內明確卸棄及免除在任何方面與申請人或代表申請人在此 時間、日期及方式公佈。 文件提供的或與此文件或在此文件下提供的任何服務相關 的任何資料，或任何申請人或代表申請人提供與此文件或 如 閣下成功申請認購香港發售股份（全部或部分） 在此文件下提供的任何服務相關的任何其他書面或口頭通 如 閣下申請認購 1,000,000 股或以上香港發售股份且已提 訊，有關或相關由申請人或任何其他人士或實體所遭受或 供申請表格所要求的資料， 閣下可於 2019 年 5 月 30 日（星 招致不論如何造成的任何損失或損害的任何法律責任。此 期四）或我們在報章通知的其他日期上午九時正至下午一時 包括但不限於，該等資料中不論如何造成的任何錯誤或遺 正，親臨我們的香港證券登記處香港中央證券登記有限公 漏，或代表或任何其他人士或實體對該等資料或任何該等 司（地址為香港灣仔皇后大道東 183 號合和中心 1712-1716 資料的文件記錄、影像、記錄或複製品作出的任何依據， 室）領取股票及╱或退款支票。 或其準確性、完整性、合時性或可靠性。

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

the Hong Kong Share Registrar to discharge their obligations to securities’ holders and/or regulators and/or any other purposes to which the securities’ holders may from time to time agree.

Personal Data

Personal Information Collection Statement

This Personal Information Collection Statement informs holders may from time to time agree. the applicant for, and holder of, Hong Kong Offer Shares, of the policies and practices of the Company 3. Transfer of personal data and its Hong Kong Share Registrar in relation Personal data held by the Company and its Hong Kong to personal data and the Personal Data (Privacy) Share Registrar relating to the securities holders will Ordinance (Chapter 486 of the Laws of Hong Kong) be kept confidential but the Company and its Hong (the “Ordinance”). Kong Share Registrar may, to the extent necessary for 1. Reasons for the collection of your personal data achieving any of the above purposes, disclose, obtain or transfer (whether within or outside Hong Kong) the It is necessary for applicants and registered holders personal data to, from or with any of the following: of securities to supply correct personal data to the ‧ the Company’s appointed agents such as financial Company or its agents and the Hong Kong Share advisers, receiving bank and overseas principal Registrar when applying for securities or transferring share registrar; securities into or out of their names or in procuring the ‧ where applicants for securities request a deposit services of the Hong Kong Share Registrar. into CCASS, HKSCC or HKSCC Nominees, Failure to supply the requested data may result in your who will use the personal data for the purposes of application for securities being rejected, or in delay or operating CCASS; the inability of the Company or its Hong Kong Share ‧ any agents, contractors or third-party Registrar to effect transfers or otherwise render their service providers who offer administrative, services. It may also prevent or delay registration or telecommunications, computer, payment or other transfers of the Hong Kong Offer Shares which you services to the Company or the Hong Kong Share have successfully applied for and/or the despatch of Registrar in connection with their respective share certificate(s) and/or refund cheque(s) to which business operation; you are entitled. ‧ the Stock Exchange, the SFC and any other It is important that securities holders inform the statutory regulatory or governmental bodies or Company and the Hong Kong Share Registrar otherwise as required by laws, rules or regulations; immediately of any inaccuracies in the personal data and supplied. ‧ any persons or institutions with which the s e curities’ holders have or propose to have 2. Purposes dealings, such as their bankers, solicitors, The personal data of the securities holders may be used, accountants or stockbrokers etc. held, processed, and/or stored (by whatever means) for the following purposes: 4. Retention of personal data ‧ processing your application and refund cheque, The Company and its Hong Kong Share Registrar will where applicable, verification of compliance with keep the personal data of the applicants and holders of the terms and application procedures set out in securities for as long as necessary to fulfil the purposes this Application Form and the Prospectus and for which the personal data were collected. Personal announcing results of allocation of the Hong Kong data which is no longer required will be destroyed or Offer Shares; dealt with in accordance with the Ordinance. ‧ compliance with applicable laws and regulations 5. Access to and correction of personal data in Hong Kong and elsewhere; ‧ Securities holders have the right to ascertain whether registering new issues or transfers into or out of the Company or the Hong Kong Share Registrar hold the names of securities’ holders including, where their personal data, to obtain a copy of that data, and to applicable, HKSCC Nominees; ‧ maintaining or upd maintaining or upd a ting the register of securities’ correct any data that is inaccurate. The Company and the Hong Kong Share Registrar have the right to charge holders of the Company; ‧ verifying securities holders’ identities; verifying securities holders’ identities; a reasonable fee for the processing of such requests. ‧ establishing benefit entitlements of securities’ All requests for access to data or correction of data holders of the Company, such as dividends, rights should be addressed to us, at our registered address issues, bonus issues, etc.; disclosed in the “Corporate Information” section of ‧ distributing communications from the Company distributing communications from the Company the Prospectus or as notified from time to time, for and its subsidiaries; the attention of the company secretary, or our Hong ‧ compiling statistical information and securities’ compiling statistical information and securities’ Kong Share Registrar for the attention of the privacy holder profiles; compliance officer.

• ‧ maintaining or upd maintaining or upd a ting the register of securities’ holders of the Company;

• ‧ verifying securities holders’ identities; verifying securities holders’ identities;

• ‧ distributing communications from the Company distributing communications from the Company and its subsidiaries;

• ‧ compiling statistical information and securities’ compiling statistical information and securities’ holder profiles;

• ‧ disclosing relevant information to facilitate claims on entitlements; and

By signing an Application Form or by giving electronic application instructions to HKSCC, you agree to all of the above.

• ‧ any other incidental or associated purposes relating to the above and/or to enable the Company and

如 閣下欲以本身名義登記將獲發行的香港發售股份，請使用本表格

個人資料

持有人及╱或監管機構承擔的責任及╱或證 券持有人不時同意的任何其他目的。

個人資料收集聲明

此項個人資料收集聲明是向香港發售股份的申請 人及持有人說明有關本公司及其香港證券登記處 有關個人資料及香港法例第 486 章個人資料（私 章個人資料（私 隱）條例（「條例」）方面的政策及常規。

3. 轉交個人資料

本公司及其香港證券登記處所持有關證券持有人 的個人資料將會保密，但本公司及其香港證券登 記處可在為達致上述任何目的之必要情況下，向 下列任何人士或機構披露、獲取或轉交（無論在 香港境內或境外）有關個人資料：

有關個人資料及香港法例第 486 章個人資料（私 章個人資料（私 的個人資料將會保密，但本公司及其香港證券登 隱）條例（「條例」）方面的政策及常規。 記處可在為達致上述任何目的之必要情況下，向 下列任何人士或機構披露、獲取或轉交（無論在 1. 收集 閣下個人資料的原因 香港境內或境外）有關個人資料： ‧ 證券申請人及登記持有人以本身名義申請證券或 本公司委任的代理，例如財務顧問、收款銀 轉讓或受讓證券時或尋求香港證券登記處的服務 行及海外主要證券登記處； ‧ 時，必須向本公司或其代理及香港證券登記處提 （倘證券申請人要求將證券存入中央結算系 供準確的個人資料。 統）香港結算或香港結算代理人；彼等將會 就中央結算系統的運作使用有關個人資料； ‧ 未能提供所要求的資料可能導致 閣下申請證券 向本公司或香港證券登記處提供與其各自業 被拒或延遲，或本公司或其香港證券登記處無法 務營運有關的行政、電訊、電腦、付款或其 落實轉讓或提供服務。此舉亦可能妨礙或延遲登 他服務的任何代理、承包商或第三方服務供 記或過戶 閣下成功申請的香港發售股份及╱或 應商； ‧ 寄發 閣下應得的股票及╱或退款支票。 聯交所、證監會及任何其他法定監管機構或 政府部門或法例、規則或規例另行規定者； 證券持有人所提供的個人資料如有任何錯誤，須 及 ‧ 立即通知本公司及香港證券登記處。 證券持有人與其進行或擬進行交易的任何人 士或機構，例如彼等的銀行、律師、會計師 2. 目的 或股票經紀等。 證券持有人的個人資料可以任何方式被採用、持 有、處理及╱或保存，以作下列用途： 4. 保留個人資料 ‧ 處理 閣下的申請及退款支票（如適用）、核 本公司及其香港證券登記處將按收集個人資料所 實是否符合本申請表格及招股章程載列的條 需的用途保留證券申請人及持有人的個人資料。 款及申請程序以及公佈香港發售股份的分配 毋須保留的個人資料將會根據條例銷毀或處理。 結果； ‧ 遵守香港及其他地區的適用法例及規例； 5. 查閱及更正個人資料 ‧ 以證券持有人（包括香港結算代理人（如適 證券持有人有權確定本公司或香港證券登記處是 用））的名義登記新發行證券或轉讓或受讓證 否持有其個人資料，並有權索取該資料的副本及 券； 更正任何不準確資料。本公司及香港證券登記處 ‧ 存置或更新本公司證券持有人的名冊； 有權就處理有關要求收取合理費用。 ‧ 核實證券持有人的身份； ‧ 確定本公司證券持有人的受益權利，例如股 所有查閱資料或更正資料的要求均應按招股章程 息、供股及紅股等； 「公司資料」一節所披露或不時通知的本公司註冊 ‧ 分發本公司及其附屬公司的通訊資料； 地址送交公司秘書，或向本公司香港證券登記處 ‧ 編製統計數據及證券持有人資料； 的私隱合規主任提出。

• ‧ 分發本公司及其附屬公司的通訊資料；

• ‧ 編製統計數據及證券持有人資料；

• ‧ 披露有關資料以便就權益索償；及

• ‧ 與上述有關的任何其他附帶或相關目的及╱ 閣下簽署申請表格或向香港結算發出電子認購指 或使本公司及香港證券登記處能履行對證券 示，即表示同意上述各項。